Hero image with Pittsburgh background https://pittplusme.org/study/2169

NO IN-PERSON VISITS
We're sorry. This study is closed and no longer recruiting participants.

STUDY BASICS

Are you at least 30 years old? Have you tested positive for COVID-19 within the past 10 days? You may be able to participate in a research study to test medications that are already approved for other diseases to see if they can help people with mild to moderate COVID-19. Participants will take a prescribed study medication or placebo and will complete online surveys. Compensation is provided.


IRB: STUDY21040161
- sIRB ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications

RESEARCH AREAS & CONDITIONS:
  COVID-19, Healthy Volunteer, Remote Research

Age Range
AGE:   30 and up
Duration
DURATION:  Up to 90 days
Location
LOCATION:  By phone & online
Compensation
COMPENSATION:  Gift card of up to $100 after completion of study
Location
PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/2169 and click on "I'm Interested" or call 1-866-438-8230.

LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Akira Sekikawa

Akira Sekikawa, MD, PhD is Professor of Epidemiology, School of Public Health, and Director, T32 Cardiovascular Epidemiology Training Program. Dr. Sekikawa graduated from a medical school in Japan and practiced there for over 10 years. Dr. Sekikawa came to Pittsburgh in 1994 to learn epidemiology as a basic science for disease prevention. His research focus lies on epidemiology of cardiovascular disease, diabetes, and dementia contrasting between the US and Japan as well as randomized controlled trials.